Human NjmuR1-related gene variant associated with lung cancers

Abstract

The invention relates to the nucleic acid and polypeptide of a novel human NjmuR1-related gene variant. The invention also relates to the process for producing the polypeptide of the variant. The invention further relates to the use of the nucleic acid and polypeptide of the gene variant in diagnosing diseases, in particular, lung, e.g. small cell lung cancer.

Dependencies are inferred from the claim text.